Concentrix Corp. Files 8-K on Officer Changes and Compensation
Ticker: CNXC · Form: 8-K · Filed: Mar 27, 2026 · CIK: 0001803599
Sentiment: neutral
Topics: officer-changes, executive-compensation, board-of-directors, filing
Related Tickers: CNXC
TL;DR
CNXC filed an 8-K: leadership changes and exec comp details out.
AI Summary
On March 25, 2026, Concentrix Corp. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing also includes information regarding the submission of matters to a vote of security holders and financial statements and exhibits. Specific details on the departures, elections, or appointments of officers and directors, as well as the nature of the compensatory arrangements, are provided within the document.
Why It Matters
This filing provides crucial updates on the company's leadership and executive pay, which can significantly impact investor confidence and strategic direction.
Risk Assessment
Risk Level: medium — Changes in officers and directors, along with executive compensation details, can signal shifts in company strategy or potential internal issues.
Key Numbers
- 0001803599-26-000092 — SEC Accession Number (Unique identifier for this specific 8-K filing)
Key Players & Entities
- Concentrix Corp. (company) — Filer of the 8-K report
- 0001803599 (company) — CIK number for Concentrix Corp.
- 2026-03-25 (date) — Period of Report for the 8-K filing
- 2026-03-27 (date) — Filing Date and Acceptance Date of the 8-K
FAQ
What specific changes were made regarding directors or certain officers?
The filing indicates Item 5.02 covers 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers,' suggesting specific personnel changes and related compensation adjustments are detailed.
What matters were submitted to a vote of security holders?
Item 5.07 of the filing addresses 'Submission of Matters to a Vote of Security Holders,' implying that shareholder votes on specific proposals are documented.
Are there any new financial statements or exhibits included with this filing?
Yes, Item 9.01 states 'Financial Statements and Exhibits,' and the document list includes 'cnxc-20260325.htm iXBRL 8-K' and an exhibit 'EX-10.1 exhibit1012026annualmeeting.htm'.
When was this 8-K filing accepted by the SEC?
The filing was accepted on 2026-03-27 at 07:34:52.
What is the CIK number for Concentrix Corp.?
The CIK number for Concentrix Corp. is 0001803599.
Filing Stats: 857 words · 3 min read · ~3 pages · Grade level 11.5 · Accepted 2026-03-27 07:34:52
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share CNXC The Nasdaq Stock Market
Filing Documents
- cnxc-20260325.htm (8-K) — 50KB
- exhibit1012026annualmeeting.htm (EX-10.1) — 7KB
- 0001803599-26-000092.txt ( ) — 176KB
- cnxc-20260325.xsd (EX-101.SCH) — 2KB
- cnxc-20260325_lab.xml (EX-101.LAB) — 22KB
- cnxc-20260325_pre.xml (EX-101.PRE) — 13KB
- cnxc-20260325_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On March 25, 2026, the Company held the Annual Meeting for which the Company's Board of Directors solicited proxies pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended. At the Annual Meeting, the Company's stockholders (1) elected nine directors to serve on the Company's Board of Directors, (2) ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2026, (3) approved, on an advisory basis, the compensation of the Company's named executive officers, and (4) approved an amendment to the 2020 Plan to increase the number of shares available for issuance thereunder. Set forth below are the final voting results for these proposals, each of which were described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on February 13, 2026: 1. The election of nine directors to serve on the Company's Board of Directors for terms expiring at the Company's 2027 Annual Meeting of Stockholders. Nominee For Withhold Broker Non-Votes Christopher Caldwell 51,981,955 331,206 4,290,089 Chih-Kai Cheng 51,618,330 694,831 4,290,089 LaVerne H. Council 51,866,198 446,963 4,290,089 Jennifer Deason 51,875,444 437,717 4,290,089 Kathryn Hayley 51,525,159 788,002 4,290,089 Kathryn Marinello 52,018,925 294,236 4,290,089 Bilge Ogut 52,102,002 211,159 4,290,089 Dennis Polk 52,018,323 294,838 4,290,089 Ann Vezina 51,872,208 440,953 4,290,089 2. The ratification of the appointment of Ernst & Young LLP as the Company's independent registered accounting firm for fiscal year 2026. For Against Abstain Broker Non-Votes 56,049,937 453,129 100,184 — 3. The approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's proxy statement. For Against Abstain Broker Non-Votes 50,8
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 10.1 Amendment No. 1 to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan, as amended, dated March 25, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 27, 2026 CONCENTRIX CORPORATION By: /s/ Jane C. Fogarty Jane C. Fogarty Executive Vice President, Legal